DudeMeds vs MEDVi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

52 providers verified independently·Independent research·How we rank →

DudeMeds beats MEDVi overall, scoring 7.8/10 vs 7.7/10. DudeMeds is more affordable at $149/mo vs $179/mo. Choose DudeMeds for patients (men and women, despite the name) who want dead-sim. Choose MEDVi for users who want a low entry price with oral and injectable co.

A side-by-side look at DudeMeds and MEDVi to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Higher Rated

DudeMeds

#13 of 52

7.8/10

Men's health telehealth platform offering compounded GLP-1 medications tailored to male patients.

Visit DudeMeds

MEDVi

#20 of 52

7.7/10

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake, one of the broader compounded mixes among independent telehealth providers in 2026.

Visit MEDVi

Feature	DudeMeds	MEDVi
Our Score	7.8/10	7.7/10
Starting Price	$149/mo	$179/mo
Medication Type	Compounded	Both
Insurance Accepted	No	No
Best For	Patients (men and women, despite the name) who want dead-simple all-in pricing at $199/mo with 48-hour shipping	Users who want a low entry price with oral and injectable compounded options
Ranking	#13	#20
Get started	Visit DudeMeds	Visit MEDVi

Pros & Cons Compared

DudeMeds

Pros

+Simplest all-in pricing: $199/mo flat covering medication, consultation, and free shipping, zero hidden fees
+48-hour medication shipping, among the fastest fulfillment times in the industry
+No doctor visit required in most states, maximally convenient for patients who don't want appointments
+Serves both men and women despite the brand name

Cons

−No video or phone consultation in most states; providers review your intake asynchronously. Maximum convenience, but pick a platform with regular check-ins if you want closer clinical oversight.
−Headquarters, founding date, and pharmacy partners aren't publicly disclosed. Ask support which pharmacy fills your prescription before ordering.
−The independent review footprint is still thin, which makes patient satisfaction claims hard to verify. Treat month one as your own trial run.

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179/mo is competitive for a platform with both oral and injectable compounded formulations

Cons

−No brand-name Wegovy or Zepbound on the platform (the 2026 expansion added branded Ozempic only)
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms; you can switch to injectable anytime at no extra fee if results lag

Our Verdict

DudeMeds edges out MEDVi with a score of 7.8/10 vs 7.7/10. If budget is your priority, DudeMeds starts at $149/mo compared to MEDVi's $179/mo. MEDVi offers both brand-name and compounded medications, giving you more flexibility. Choose DudeMeds if you want: patients (men and women, despite the name) who want dead-simple all-in pricing at $199/mo with 48-hour shipping. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.

Still undecided? Editor's Featured Pick

Yucca Health

$146/mo · 7.7/10 · Compounded

If neither DudeMeds nor MEDVi feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.

Visit Yucca Health→Read our full Yucca Health review